NFH
ZYNE

NEXT Financial Holdings’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

NEXT Financial Holdings’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1K Buy
+150
New +$730 ﹤0.01% 1601

Other funds holding ZYNE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Campbell Capital Management Miami, Florida $279M AUM 49.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
PP
PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return

NEXT Financial Holdings's ZYNE Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Zynerba Pharmaceuticals, Inc (ZYNE) in Q1 2019: 150 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1601 among its holdings.

61 funds tracked by Wall St. Rank hold ZYNE as of Q1 2019.

  • NEXT Financial Holdings held 150 shares of Zynerba Pharmaceuticals, Inc worth $1K as of Q1 2019.
  • Zynerba Pharmaceuticals, Inc was a new NEXT Financial Holdings position in Q1 2019.
  • Zynerba Pharmaceuticals, Inc made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1601 holding.
  • 61 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.